![Maryann Cimino](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profiel
Maryann Cimino is currently the Director-Investor Relations at IO Biotech, Inc. She previously worked as the Director-Investor Relations & Corporate Affairs at Kiadis Pharma NV.
Actieve functies van Maryann Cimino
| Bedrijven | Functie | Begin |
|---|---|---|
| IO BIOTECH, INC. | Investor Relations Contact | 01-04-2023 |
Eerdere bekende functies van Maryann Cimino
| Bedrijven | Functie | Einde |
|---|---|---|
| KIADIS PHARMA N.V. | Investor Relations Contact | 01-06-2021 |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
19
Eerstegraads connecties
2
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 2 |
|---|---|
Kiadis Pharma NV
 Kiadis Pharma NV Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company focused on research, development and commercialization of cell based immunotherapy products | Health Technology |
IO Biotech, Inc.
 IO Biotech, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops novel, immune-modulating cancer therapies | Health Technology |
